LINEAGE CELL THERAPEUTICS IN

Ticker: LCTX CUSIP: 53566P109 Class: COM

AMERIPRISE FINANCIAL INC's Holding History (CIK: 0000820027)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 23,500 Value ($000) $21 Avg Close $0.59 Range $0.37 - $1.15
Q1 2025
Shares 46,897 Value ($000) $21 Avg Close $0.59 Range $0.45 - $0.75
Q4 2024
Shares 42,878 Value ($000) $22 Avg Close $0.73 Range $0.48 - $0.97
Q3 2024
Shares 23,500 Value ($000) $21 Avg Close $0.93 Range $0.77 - $1.15
Q2 2024
Shares 23,660 Value ($000) $24 Avg Close $1.10 Range $0.84 - $1.56
Q1 2024
Shares 23,660 Value ($000) $35 Avg Close $1.13 Range $0.84 - $1.61
Q4 2023
Shares 25,660 Value ($000) $28 Avg Close $1.10 Range $0.90 - $1.37
Q3 2023
Shares 25,660 Value ($000) $30 Avg Close $1.36 Range $1.15 - $1.54
Q2 2023
Shares 25,674 Value ($000) $36 Avg Close $1.38 Range $1.24 - $1.57
Q1 2023
Shares 25,674 Value ($000) $39 Avg Close $1.40 Range $1.16 - $1.58
Q4 2022
Shares 25,660 Value ($000) $30 Avg Close $1.26 Range $1.02 - $1.51
Q3 2022
Shares 69,260 Value ($000) $78 Avg Close $1.47 Range $1.11 - $1.79
Q2 2022
Shares 40,660 Value ($000) $64 Avg Close $1.32 Range $1.10 - $1.64
Q4 2021
Shares 304,989 Value ($000) $747 Avg Close $2.34 Range $1.80 - $2.71